Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price dropped 0.8% during trading on Monday . The stock traded as low as $3.33 and last traded at $3.41. Approximately 252,267 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 387,361 shares. The stock had previously closed at $3.44.
Ono Pharmaceutical Stock Down 0.8%
The company has a 50-day moving average price of $3.73 and a 200 day moving average price of $3.64.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Why Are These Companies Considered Blue Chips?
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Pros And Cons Of Monthly Dividend Stocks
- What Ray Dalio’s Latest Moves Tell Investors
- What Is WallStreetBets and What Stocks Are They Targeting?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
